Skip to main content

Table 1 The roles of USP17 in different types of cancers

From: The role of the deubiquitinating enzyme DUB3/USP17 in cancer: a narrative review

Cancer type

Targets

Functions

References

Central nervous system cancer

Ras and Myc

Inhibits the carcinogenesis and proliferation of glioma

[35]

CDC25A

Negatively regulates cell cycle progression and proliferation of glioma

[36]

Head and neck cancer

BRD4/EZH2

Promotes the proliferation of OSCC cells and inhibits apoptosis

[37]

Snail1

Promotes the epithelial mesenchymal transition (EMT)

[38]

Thoracic cancer

Cyclin A

Drives cell cycle progression and promotes lung cancer cell proliferation

[41]

Transferrin and its receptor (TfR)

Promotes the growth of EGFR mutation lung cancer cells and inhibits apoptosis

[43]

TRAF2 and TRAF3

Upregulates the inflammation-related genes and stemness-related genes in cancer cells

[45]

HAS2

Triggers the progression of cancer

[47]

MMP3 and MMP9

Promotes the tumorigenesis and growth

[48]

PI3K/Akt

Contributes to cisplatin resistance in NSCLC cells

[49]

Breast cancer

AEP

Promotes the intracellular stability and metastasis

[50]

SET8

Increases the proliferation of breast cancer cells

[53]

Snail, Slug and Twist

Promotes EMT and breast cancer metastasis; cancer stem cell-like characteristics of breast cancer cells

[54, 56]

CDC25A

Promotes cell cycle progression

[58]

Geminin

Enhances genomic instability, DNA replication change, aneuploidy, and cancer progression

[61]

MAPK signaling pathway

Decreases the cell viability

[62]

Gastrointestinal cancer

H2AX

Overcomes DNA double-strand break (DSB)

[66, 68]

DEC1

Recovers from G2 DNA damage checkpoint

[69]

Nrf2

Leads to chemotherapy resistance

[70]

Genitourinary cancer

NF-κB/ROS

Promotes the proliferation, migration, and invasion of prostate cancer cells and inhibits apoptosis

[72]

BRD4

Leads to drug resistance of BET inhibitor

[73]

Gynecologic cancer

SDS3

Induces apoptosis and inhibits cell proliferation in cervical adenocarcinoma cells

[74]

Ras

Decreases growth of Hela cells

[77]

ELK-1

Promotes cell proliferation

[80]

Rho GTPases

Promotes cell migration and cytoskeleton reorganization

[81]

MCL1

Regulates chemoresistance in ovarian cancer

[85]

Bone and soft tissue sarcomas

Smad4

Enhances the migration and invasion of osteosarcoma cells through activation of EMT

[86]

  1. AEP asparaginyl endopeptidase, Akt protein kinase B, BET bromodomain and extra-terminal domain, BRD4 bromodomain-containing protein 4, CDC25A cell division cycle 25A, DEC1 defective chorion-1, EGFR epidermal growth factor receptor, ELK-1 ETS-like protein 1, EZH2 enhancer of zeste homolog-2, H2AX H2A histone family member X, HAS2 hyaluronan synthase 2, MAPK mitogen-activated protein kinase, MCL1 myeloid cell leukemia sequence 1, MMP3 matrix metallopeptidase 3, OSCC oral squamous cell carcinoma, PI3K phosphoinositide-3-kinase, ROS reactive oxygen species, SDS3 suppressor of defective silencing 3, SET8 SET domain-containing protein 8, TRAFs tumor necrosis factor receptor associated factors